This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction
treated with primary angioplasty: a meta-regression analysis of randomized trials
by Giuseppe De Luca, Eliano Navarese, and Paolo Marino
(A) Weighted random-effects meta-regression analysis regressing the log odds ratio of mortality against the control group mortality rate expressed as odds using the inverse of the variance of the log odds ratio as weight; this graph shows a relationship between risk profile and mortality
benefits from Gp IIb-IIIa inhibitors.
Giuseppe De Luca et al. Eur Heart J 2009;30:2705-2713
(A) Weighted random-effects meta-regression analysis regressing the log odds ratio of re-infarction against the control group re-infarction rate expressed as odds using the inverse of the
variance of the log odds ratio as weight; this graph shows no relationship between risk profile and benefits in re-infarction from Gp IIb-IIIa inhibitors.
Giuseppe De Luca et al. Eur Heart J 2009;30:2705-2713